Abstract
The human dopamine D2L receptor couples promiscuously to multiple members of the Gαi/o subfamily. Despite the high homology of the D2L and D3 receptors, the G protein coupling specificity of the human D3 receptor is less clearly characterized. The primary aim of this study, then, was the parallel characterization of the G protein coupling specificity of the D2L and D3 receptors. By using both receptor-G protein fusion proteins and stable cell lines in which pertussis toxin-resistant mutants of individual Gαi-family G proteins were expressed in an inducible fashion, we demonstrated highly selective coupling of the D3 receptor to Gαo1. Furthermore, by using the fusion proteins to ensure identical stoichiometry of receptor to G protein for each pairing, a range of ligands displayed higher potency and, for partial agonists, higher efficacy at the D3 receptor when coupled to Gαo1 compared with the D2L receptor. The second aim of this study was to investigate the molecular basis of the above differential G protein coupling specificity. The importance of a 12-amino acid sequence from the C-terminal end of the third intracellular loop of the D2L receptor in providing promiscuity in G protein coupling was demonstrated using a chimeric D3/D2 receptor in which the equivalent region of the D3 receptor was exchanged for this sequence. This chimera displayed D3-like affinity for [3H]spiperone and potency for agonists but gained D2-like ability to couple to each of Gαi1–3 as well as Gαo1.
Footnotes
-
J.R.L. was supported by a Biotechnology and Biosciences Research Council Collaborative Award in Science and Engineering studentship.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.107.134296.
-
ABBREVIATIONS: D2L, long isoform of the human dopamine D2 receptor; GTPγS, guanosine 5′-O-(thiotriphosphate); D3, human dopamine D3 receptor; HEK, human embryonic kidney; R-(+)-3-PPP, R (+) 3-(3-hydroxyphenyl)-N-propylpiperidine; NPA, R-(–)-10,11-dihydroxy-N-n-propylnorapomorphine; 7-OH-DPAT, R(+)-7-hydroxy-dipropylaminotetralin hydrobromide; PCR, polymerase chain reaction; ANOVA, analysis of variance; TM, transmembrane domain; GPCR, G protein-coupled receptor; S-(–)-3-PPP, S-(–)-3-(3-hydroxyphenyl)-N-propylpiperidine; [35S]GTPγS, guanosine 5′-O-(3-[35S]thio)triphosphate.
- Received November 14, 2007.
- Accepted January 23, 2008.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|